This technique was applied to iPSC-derived dopaminergic neurons from a PD patient resulting in hypermethylation of the SNCA gene, downregulation of the SNCA expression, and a reversion of disease-related phenotypic perturbations [65]. The gene discussed is SNCA; the disease is Parkinson disease.